NCT05798234

Brief Summary

To determine the factors associated with OHD failure in COVID-19 patients admitted to an Intensive Care Unit

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 3, 2023

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 4, 2023

Completed
27 days until next milestone

Study Start

First participant enrolled

May 1, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

April 4, 2023

Status Verified

April 1, 2023

Enrollment Period

4 months

First QC Date

April 3, 2023

Last Update Submit

April 3, 2023

Conditions

COVID-19 Pneumonia

Outcome Measures

Primary Outcomes (1)

  • High flow oxygen failure

    patients requiring initial high flow oxygen but finally intubated

    icu stay duration

Interventions

high flow oxygen deviceDEVICE

no intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Consecutive patients

You may qualify if:

  • Patients admitted in ICU for COVID-19 pneumonia

You may not qualify if:

  • under immediate ECMO
  • secondary transferred from another ICU
  • readmission in the ICU
  • initial limitation of care

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de Réanimation Médicale, Hôpital Central

Nancy, France

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 3, 2023

First Posted

April 4, 2023

Study Start

May 1, 2023

Primary Completion

September 1, 2023

Study Completion

December 1, 2023

Last Updated

April 4, 2023

Record last verified: 2023-04

Locations

FR(1)